BRIEF-Elan says FDA grant fast track status to alzheimers treatment

LONDON, July 17 (Reuters) - Elan Corporation PLC : * FDA grant fast track designation to ELND005 for the treatment of
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.